AEON Biopharma Reduces Warrant Exercise Price and Expects $6.2 Million in Gross Proceeds

Filing content

The company amended its two-year milestone warrants to reduce the exercise price to $0.20 per share, expecting approximately $6.2 million in gross proceeds from the resulting warrant exercises.